secwatch.observer — SEC 8-K summary
======================================

Issuer:     LeonaBio, Inc. (LONA)
CIK:        0001620463
Form:       8-K
Filed at:   2025-09-11T23:59:59+00:00
Accession:  0000950170-25-114093
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Athira Pharma to effect 10-for-1 reverse stock split on Sep 17 to meet Nasdaq minimum bid price
--------------------------------------------------------------------------------

- Effective Sept 17 at 5pm ET; shares start trading split-adjusted on Sep 18 under ticker ATHA.
- Every 10 pre-split shares convert to 1; authorized common shares reduced from 900M to 90M.
- Purpose: increase share price to comply with Nasdaq's $1.00 minimum bid requirement.
- Fractional shares paid in cash; CUSIP changes to 04746L203.
- No action needed by book-entry or street-name holders; Computershare is exchange agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1620463/000095017025114093/0000950170-25-114093-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1620463/000095017025114093/atha-20250910.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-114093

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer